Condensed Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Net Sales		$ 2,556,223	$ 2,688,533	$ 5,191,941	$ 5,064,926
Cost of Sales		1,272,176	1,493,566	2,703,660	2,853,799
Gross Profit		1,284,047	1,194,967	2,488,281	2,211,127
Operating Expenses
Selling expenses		309,179	405,212	636,775	964,682
General and administrative expenses		1,170,842	1,287,937	2,240,450	2,481,802
Research and development		520	(518)	910	750,698
Total Operating Expenses		1,480,541	1,692,631	2,878,135	4,197,182
Loss From Operations		(196,494)	(497,664)	(389,854)	(1,986,055)
Other Income (Expenses)
Non-operating income		376	1,162	77,269	2,743
Loss on impairment of goodwill				(218,606)
Foreign exchange transaction income (loss)		(28,063)	(2,383)	(32,050)	70,649
Interest expense, net		(10,927)	(8,626)	(18,689)	(12,568)
Financial expense		(55,796)	(51,102)	(110,105)	(96,138)
Total Other Expenses, Net		(94,410)	(60,949)	(302,181)	(35,314)
Loss Before Income Taxes		(290,904)	(558,613)	(692,035)	(2,021,369)
Income Tax Benefit (Expense)		997	(4,876)	63,257	(4,876)
Net Loss		(289,907)	(563,489)	(628,778)	(2,026,245)
Other Comprehensive Loss
Foreign currency translation		(23,731)	(909)	(26,706)	(82,600)
Net Loss and Comprehensive Loss		$ (313,638)	$ (564,398)	$ (655,484)	$ (2,108,845)
Weighted average shares outstanding - Basic	[1]	13,729,976	2,538,792	11,766,186	2,387,653
Weighted average shares outstanding - Diluted	[1]	13,729,976	2,538,792	11,766,186	2,387,653
Net loss per share of common stock
Basic		$ (0.02)	$ (0.22)	$ (0.05)	$ (0.85)
Diluted		$ (0.02)	$ (0.22)	$ (0.05)	$ (0.85)

[1] Including 1,500 and 0 shares that were granted and vested but not yet issued for the six and three months ended June 30, 2025 and 2024, respectively.